Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi Arabia
Drug development, from preclinical to clinical studies, is a lengthy and complex process. There is an increased interest in the Kingdom of Saudi Arabia (KSA) to promote innovation, research and local content including clinical trials (Phase I-IV). Currently, there are over 650 registered clinical tr...
Saved in:
Main Authors: | Abdullah Alsultan (Author), Wael A. Alghamdi (Author), Jahad Alghamdi (Author), Abeer F. Alharbi (Author), Abdullah Aljutayli (Author), Ahmed Albassam (Author), Omar Almazroo (Author), Saeed Alqahtani (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and Genetic Characterization of Craniosynostosis in Saudi Arabia
by: Malak Alghamdi, et al.
Published: (2021) -
Clinical characteristics and predictors of mortality among COVID-19 patients in Saudi Arabia
by: Olayan Albalawi, et al.
Published: (2021) -
Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia
by: Bander Balkhi, et al.
Published: (2023) -
Current status of telehealth in Saudi Arabia during COVID-19
by: Saeed M Alghamdi, et al.
Published: (2020) -
Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA region
by: Mohammed S. Alasmari, et al.
Published: (2024)